PharmaShots Weekly Snapshot (May 11-15, 2020)

1. Janssen to Present Updated Results of JNJ-4528 in P-Ib/II CARTITUDE-1 Study for Multiple Myeloma at ASCO 2020

Published: May 14, 2020 | Tags: Janssen, Update, Results, JNJ-4528, P-Ib/II, CARTITUDE-1, Study, Multiple Myeloma, ASCO

2. Samsung Bioepis Reports Results of Ontruzant (biosimilar, trastuzumab) in P-III Follow-up Study (SB3-G31-BC-E) for Early or Locally Advanced HER2-Positive Breast Cancer

Published: May 15, 2020 | Tags: Samsung Bioepis, Reports, Results, Ontruzant, biosimilar, trastuzumab, P-III, Follow-up, Study, SB3-G31-BC-E, Early, Locally Advanced, HER2-Positive, Breast Cancer

3. Recursion Signs a Worldwide License Agreement with Takeda to Develop TAK-733 for Hereditary Cancer Syndrome

Published: May 14, 2020 | Tags: Recursion, Signs, Worldwide, License Agreement, Takeda, Develop, TAK-733, Hereditary Cancer Syndrome

4. Roche Launches v-TAC Blood Gas Digital Solution for Improving Patient Care

Published: May 15, 2020 | Tags: Roche, Launches, v-TAC, Blood Gas Digital Solution, Improving, Patient Care

5. Sanofi’s COVID-19 Vaccine to be Available Globally

Published: May 15, 2020 | Tags: Sanofi, COVID-19, Vaccine, Available, Globally

6. Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline to Bolster its Immuno-oncology Portfolio

Published: May 14, 2020 | Tags: Boehringer Ingelheim, Acquires, Northern Biologics, Preclinical, Cancer, Antibody Pipeline, Bolster, Immuno-oncology Portfolio

7. Innovent and Eli Lilly Report Results of TYVYT (sintilimab) in P-II ORIENT-2 Study as 2L Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Published: May 13, 2020 | Tags: Innovent, Eli Lilly, Report, Results, TYVYT, sintilimab, P-II, ORIENT-2 Study, 2L, Treatment, Advanced, Metastatic, Esophageal Squamous Cell Carcinoma

8. Roche to Present Results of Tiragolumab in P-II CITYSCAPE Study for Non-Small Cell Lung Cancer at ASCO20

Published: May 14, 2020 | Tags: Roche, Reports, Results, Tiragolumab, P-II, CITYSCAPE, Study, Non-Small Cell Lung Cancer, ASCO

10. Novocure and ZaiLab’s Optune Receive NMPA’s Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

Published: May 13, 2020 | Tags: Novocure, ZaiLab, Optune, Receives, NMPA, Approval, Treatment, Newly Diagnosed, Recurrent Glioblastoma

11. Sanofi’s Sutimlimab Receives the US FDA’s Priority Review to Treat Hemolysis Patients with Cold Agglutinin Disease

Published: May 14, 2020 | Tags: Sanofi, Sutimlimab, Receives, US, FDA, Priority Review, Treat, Hemolysis Patients, Cold Agglutinin Disease

12. BMS and bluebird bio to Resubmit the BLA for Idecabtagene Vicleucel (ide-cel, bb2121) to Treat Patients with Multiple Myeloma

Published: May 13, 2020 | Tags: US, FDA, Refuses, Review, BMS, bluebird bio, Idecabtagene Vicleucel, ide-cel, bb2121, Multiple Myeloma

13. LifeScan Collaborates with Noom to Launch Digital Diabetes and Weight Loss Management Program

Published: May 12, 2020 | Tags: LifeScan, Collaborates, Noom, Launch, Digital Diabetes, Weight Loss, Management Program

14. Skyhawk Therapeutics Expands its Agreement with Merck to Develop Novel Small Molecules Modulating RNA Splicing

Published: May 12, 2020 | Tags: Skyhawk Therapeutics, Expands, Agreement, Merck, Develop, Novel, Small Molecules, Modulating, RNA Splicing

15. Alvotech Reports Results of AVT02 (a proposed biosimilar to adalimumab) in Two Clinical Studies for Autoimmune Diseases

Published:  May 12, 2020 | Tags: Alvotech, Reports, Results, AVT02, proposed biosimilar, HUMIRA, (adalimumab), Two, Clinical Studies, Autoimmune Diseases

16. Moderna’s mRNA-1273 Receives the US FDA’s Fast Track Designation to Treat COVID-19

Published: May 12, 2020 | Tags: Moderna, mRNA-1273, Receives, US, FDA, Fast Track Designation, Treat, COVID-19

17. Gilead Collaborates with Generics Makers to Supply Remdesivir in 127 Countries

Published: May 12, 2020 | Tags: Gilead, Collaborates, Generics Makers, Supply, Remdesivir, 127 Countries

18. GRYT Health and BMS Sign an Agreement to Launch Virtual Platform COVID Advocacy Exchange

Published: May 12, 2020 | Tags: GRYT Health, BMS, Sign, Agreement, Launch, Virtual Platform, COVID, Advocacy Exchange

19. Abbott Receives FDA’s Emergency Use Authorization for its Fourth Ab Blood Test to Detect COVID-19

Published: May 11, 2020 | Tags: Abbott, Receives, FDA, Emergency Use Authorization, Fourth, Ab Blood Test, Detect, COVID-19

20. Novartis Signs an Agreement with Dyno to Develop Novel AVV Therapies Utilizing AI Technology for Ocular Diseases

Published: May 04, 2020 | Tags: Novartis, Signs, Agreement, Dyno, Develop, Novel, AVV Therapies, Utilizing, AI Technology, Ocular Diseases

21. PharmaMar Signs an Exclusive License Agreement with MegaPharm for Lurbinectedin

Published:  May 12, 2020 | Tags:  PharmaMar, Signs, Exclusive, License Agreement, MegaPharm, Lurbinectedin

22. Neurocrine Biosciences Exercises its Option with Idorsia for ACT-709478

Published: May 12, 2020 | Tags: Neurocrine Biosciences, Exercises, Option, Idorsia, ACT-709478

23. Sanofi Reports Results of Sarclisa (isatuximab) in P-III IKEMA trial in Patients with Relapsed Multiple Myeloma

Published: May 12, 2020 | Tags: Sanofi, Reports, Results, Sarclisa, isatuximab, P-III, IKEMA, Patients, Relapsed, Multiple Myeloma

24. Eli Lilly’s Retevmo (selpercatinib) Receives the US FDA’s Approval as the First Therapy to Treat Advanced RET-Driven Lung and Thyroid Cancers

Published: May 08, 2020 | Tags: Eli Lilly, Retevmo, (selpercatinib), Receives, US, FDA, Approval, First, Therapy, Treat, Advanced, RET-Driven, Lung, Thyroid Cancers

25. Regeneron’s RGC Signs a Research Collaboration with Colorado Center to Advance the Drug Discovery for Personalized Medicine

Published: May 11, 2020 | Tags: Regeneron, RGC, Signs, Research, Collaboration, Colorado Center,  Advance, Drug Discovery, Personalized Medicine

26. Sorrento Collaborates with Mount Sinai Health System to Develop COVI-SHIELD Antibody Cocktail Targeting COVID-19

Published: May 08, 2020 | Tags: Sorrento, Collaborates, Mount Sinai Health System, Develop, COVI-SHIELD, Antibody Cocktail, Targeting, COVID-19

27. AstraZeneca Terminates Their License Agreement with Allergan for Brazikumab Signed in 2016

Published: May 11, 2020 | Tags: AstraZeneca, Terminates, License Agreement, Allergan, Brazikumab, Signed, 2016

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post